Chr. Hansen Holding A/S
- ExchangeNasdaq Nordic Copenhagen
- SectorPharmaceuticals & Biotechnology
Resolutions passed at the Annual General Meeting of Chr. Hansen Holding A/S Company Announcement No. 26/2019November 27, 2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: Annika Stern, Investor Relations Officer, Tel: Camilla Lercke, Head of Media Relations, Tel: About Chr. Hansen Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natur...
Feasibility Study Results in December to be a Catalyst for this Junior